Home
Live Updates
Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities : comparemela.com
Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities
/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...
Related Keywords
,
George Perry ,
Alan Tuchman ,
Nemoursai Dupont ,
National Cancer Institute ,
National Institute Of Health ,
National Institutes Of Health ,
Drug Administration ,
Nasdaq ,
Synaptogenix Inc ,
Exchange Commission ,
Prnewswire Synaptogenix Inc ,
National Institute On Aging ,
National Institute ,
Synaptogenix Chief Executive Officer ,
Cleveland Clinic ,
Exploratory Endpoints ,
Post Hoc ,
Scientific Advisory Board Chair ,
Severe Impairment Battery ,
Mini Mental State Examination ,
Sponsored Phase ,
National Institutes ,
Orphan Drug Designation ,
Synaptogenix ,
Nc ,
comparemela.com © 2020. All Rights Reserved.